List of assays available for PDSP Psychoactive Drug Screening Program:
B: Binding Assay, F:Functional Assay, *:Under Development,
all are cloned except where marked **
Not available ***
h:human, m:mouse, r:rat, rab:rabbit
| Acetylcholine receptors |
| Muscarinic receptor |
B |
F |
| h M1 |
h M2 |
h M3 |
h M4 |
h M5 |
| Nicotinic receptor |
B |
|
| a2/b2 |
a2/b4 |
a3/b2 |
a3/b4 |
a4/b2 |
a4/b4 |
|
| Adenosine receptor |
B |
F |
| h ADORA1 |
h ADORA2A |
h ADORA2B |
h ADORA3 |
|
| Adrenergic receptor |
B |
F |
| Alpha 1A |
Alpha 1B |
Alpha 1D |
Alpha 2A |
Alpha 2B |
Alpha 2C |
| h Beta1* |
h Beta2* |
h Beta3* |
|
| Angiotensin receptor |
B |
|
| Angiotensin II AT1 |
Angiotensin II AT2 |
|
| Cannabinoid |
B |
F |
| Cannabinoid 1 |
Cannabinoid 2 |
|
| Chemokine |
F |
| h CCR01 |
h CCR02 |
h CCR03 |
h CCR04 |
h CCR05 |
h CCR06 |
| h CCR07 |
h CCR08 |
h CCR09 |
h CCR10 |
h CCRL1 |
h CCRL2 |
|
| Dopamine receptor |
B |
F |
| h D1* |
h D2 |
r D3 ** |
h D4 |
h D5* |
|
| GABA receptor |
B |
|
| r GABAa ** |
r GABAb ** |
r BZP ** |
| GABA BZP(a1) |
GABA BZP(a2) |
GABA BZP(a3) |
GABA BZP(a5) |
GABA BZP(a6) |
|
| Glutamate receptor |
B |
|
| r NMDA ** |
r PCP ** |
r AMPA *, ** |
r Kainate*, ** |
| h NR1 |
h NR2B |
|
| Metabotropic Glutamate receptor |
B |
F |
| mGluR1 |
mGluRII |
h mGluR4 |
r mGluR4 ** |
h mGluR5a |
r mGluR5 ** |
| mGluRVI |
r mGluR7 ** |
mGluRVIII |
|
Endothelial differentiation, lysophosphatidic acid, EDG receptor |
|
F |
| h EDG02 |
h EDG03 |
h EDG4 |
h EDG05 |
h EDG06 |
| h EDG07 |
h EDG08 |
|
| Histamine receptor |
B |
F |
| h H1 |
h H2 |
h H3* |
h H4 |
|
| Imidazoline receptor |
B |
|
| r I1 ** |
r I2 ** |
|
| Melanin Concentrating Hormone receptor |
F |
| h melanin concentrating hormone receptor 1 |
h melanin concentrating hormone receptor 2 |
|
| Melanocortin receptor |
F |
| h MC1 |
h MC2 |
h MC3 |
h MC4 |
h MC5 |
|
| Opiate receptor |
B |
F |
| DOR |
KOR |
MOR |
ORL-1 |
|
| Orphan receptor |
|
F |
| h GPR115 |
h GPR123 |
h GPR125 |
h GPR128 |
h GPR133 |
h GPR157 |
| h GPR21 |
h GPR26 |
h GPR40 |
h GPR41 |
h GPR43 |
h GPR45 |
| h GPR58 |
h GPR61 |
h GPR62 |
h XCR01 |
|
| Peptide receptor |
F |
| h C3AR1 complement component 3A |
h C5L2 |
h C5R01 |
h CALCR |
| h CCBP2 |
h CMKL1 |
h CMKL2 |
h CRHR1 |
h CRHR2 |
| h FPRL1 |
h FPRL2 |
h GCGR |
h GHRHR |
h GIPR |
h GLP1R |
| h GLP2R |
h GLUH1 |
h HAMEP1 |
h LTB4R |
h LTB4R2 |
h MASS1 |
| h NMUR1 |
h NMUR2 |
h Neurotensin NTII |
h Orexin 2 |
Oxytocin |
| h PNR |
h PTHR1 |
h PTHR2 |
h SALPR |
h SCTR |
h SSTR1 |
| h SSTR2 |
h SSTR3 |
h SSTR4 |
h SSTR5 |
h TM7SF1 |
h VIPR2 |
| h UROII urotensin |
h motilin receptor/GPR38/ghrelin |
| Bradykinin |
F |
| h BDKRB1 |
h BDKRB2 |
| Corticotropin Releasing Factor |
B |
|
| CRFR1* |
CRFR2* |
| Cysteinyl leukotriene |
F |
| h CLR01 |
h CLR02 |
| Neurokinin |
F |
| h NK-1 |
h NK-2* |
h NK-3* |
| Neuropeptide Y |
B |
F |
| h NPY-Y1* |
h NPY-Y2* |
h NPYR4 |
h NPYR5 |
| Vasopressin receptor |
B |
F |
| V1 |
V2 |
V3 |
|
| Prostaglandin receptor |
B |
F |
| EP1* |
rab EP2 |
EP3 |
rab EP4 |
h PTGIR I2 (prostacyclin) |
|
| Protein Kinase C |
B |
|
| a-PKC |
b-PKC |
d-PKC |
e-PKC |
g-PKC |
|
| Purinergic receptor |
F |
| h P2RY1 |
h P2RY2 |
h P2RY4 |
h P2RY6 |
h P2RY11 |
h P2RY12 |
|
| Serotonin receptor |
B |
F |
| h 5HT1A |
h 5HT1B |
h 5HT1D |
h 5HT1E* |
h 5HT1F* |
| h 5HT2A |
r 5HT2A ** |
h 5HT2B |
h 5-HT2C-INI |
h 5-HT2C-VGI |
| h 5HT3 |
h 5HT4* |
h 5HT5A |
h 5HT6 |
h 5HT7A |
| h 5HT7B |
|
| Transporters |
B |
F |
| SERT |
NET |
DAT |
h VMAT1*** |
h VMAT2*** |
|
| Others |
F |
| h EDNRA |
h EDNRB |
h EDNRBL |
h EMR1 |
h EMR2 |
h EMR3 |
| h FPR01 |
h FSK80 |
h BPZP |
| r Sigma 1 ** |
r Sigma 2 ** |
| NA+ channel site II *** |
r CA2+ channel ** |
| HERG |
MDR-1 |
|